Revolution Medicines Secures Powerhouse $2B Funding in Groundbreaking Royalty Pharma Deal
Revolution inks $2B flexible deal with Royalty Pharma to fund RAS(ON) inhibitors in cancer.
Read More
Category: Dealstreet
Alexion Strikes Bold AI Partnership for Rare Disease Detection
AI partnership targets rare bone disease affecting 1 in 6,000 patients.
Read MoreOwens & Minor Scraps $1.4B Rotech Deal Amid FTC Opposition
Medical distributor abandons home healthcare consolidation play.
Read More
Stryker Acquires Inari Medical: Strategic Expansion into Peripheral Vascular Treatment Market
Stryker Completes $3.1 Billion Acquisition of Inari Medical, Entering High-Growth Venous...
Read MoreBain Capital Acquires Mitsubishi Tanabe Pharma
Bain Capital, a leading global private investment firm with approximately $160 billion in assets under management, has announced its agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC), a renowned Japanese...
Read More